Danaher | DHR - Gewinn Vor Steuern

Aktienkurs
178.80
Täglich Wechseln
-0.18 -0.10%
Monatlich
-2.77%
Jährlich
-10.30%
Q2 Prognose
173.46




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 442M 1000K 2025-09
Align Technology USD 176.6M 81.86M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
Bio-Rad Laboratories USD 82.9M 331.1M 2025-09
Boston Scientific USD 700M 238M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -230M 77M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
ESCO Technologies USD 59.57M 26.5M 2025-09
Fortive USD 135M 57M 2025-09
Henry Schein USD 137M 16M 2025-09
Illumina USD 220M 86M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
IQVIA Holdings USD 537M 5.62B 2025-12
Keysight Technologies USD 385M 39M 2025-09
Laboratory Of America USD 337M 32.3M 2025-09
Medtronic USD 2.1B 224M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Quidel USD -756.9M 527.3M 2025-09
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Roper Industries USD 534.6M 36.4M 2025-12
Stryker USD 1.03B 13M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Waters USD 170.12M 7.57M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12